SCIENCE WATCH

Renal Response to Tissue Injury

Lessons from Heme Oxygenase-1 Gene Ablation and Expression

ANUPAM AGARWAL and HARRY S. NICK
JASN May 2000, 11 (5) 965-973;

Abstract

Abstract. Heme oxygenase-1 (HO-1) is a microsomal enzyme involved in the degradation of heme, resulting in the generation of biliverdin, iron, and carbon monoxide. Recent attention has focused on the biologic effects of product(s) of this enzymatic reaction that have important antioxidant, anti-inflammatory, and cytoprotective functions. Induction of HO-1 occurs as an adaptive and beneficial response to a wide variety of oxidant stimuli, including heme, hydrogen peroxide, cytokines, growth factors, heavy metals, nitric oxide, and oxidized LDL. HO-1 has been implicated in several clinically relevant disease states, including transplant rejection, hypertension, acute renal injury, atherosclerosis, and others. Previous studies indicate a protective role for HO-1 in heme and non-heme-mediated models of acute renal injury using chemical inducers and inhibitors of HO-1. Studies in HO-1 knockout mice further corroborate these observations, highlighting the important role of HO-1 in the pathophysiology of acute renal injury. Expression of HO-1 has been linked to prolonged xenograft survival and is important in transplant rejection as well. More recently, the first known case of human HO-1 deficiency was reported with several phenotypical similarities to the mouse HO-1 knockout. The role of HO-1 has extended far beyond its initial description as an enzyme involved in heme degradation to being an important mediator in modulating adaptive and protective responses not only in renal injury, but in other organ systems as well.

Cellular heme derived from ubiquitously disposed heme proteins such as cytochromes, peroxidases, respiratory burst oxidases, pyrrolases, catalase, nitric oxide synthases, hemoglobin, and myoglobin is degraded by the heme oxygenase enzyme system (1). The heme oxygenase enzyme opens the heme ring, resulting in the liberation of equimolar quantities of biliverdin, iron, and carbon monoxide (CO), as shown in Figure 1. Biliverdin is subsequently converted to bilirubin by biliverdin reductase. Since 1968, when Tenhunen, Marver, and Schmid (2,3) first described the rate-limiting enzymatic reaction catalyzed by heme oxygenase, interest in this field has extended beyond just the heme-degrading function of this enzyme. Recent attention has centered on the biologic effects of the reaction product(s) that potentially possess important antioxidant, anti-inflammatory, antiapoptotic, and possible immune modulatory functions (4,5,6,7,8,9,10,11,12,13,14). The cytoprotective attributes of heme oxygenase activity were recognized as a consequence of its robust induction as an adaptive response in cells/tissues exposed to a wide variety of injurious stimuli. These include heme, ultraviolet radiation, hydrogen peroxide, cytokines, endotoxin, growth factors, heavy metals, oxidized LDL, shear stress, hyperoxia, nitric oxide (NO), and NO donors—all stimuli imposing a significant shift in cellular redox (4,5,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32).

Figure 1.
Figure 1.

The heme oxygenase catalyzed reaction. Heme (iron protoporphyrin IX) is cleaved between rings A and B by heme oxygenase to yield equimolar quantities of iron (Fe3+), carbon monoxide (CO), and biliverdin. O2 and NADPH are required for this reaction. Biliverdin is then converted to bilirubin by biliverdin reductase. M, V, and P represent methyl, vinyl, and propionyl groups, respectively.

Two isoforms of heme oxygenase have been extensively characterized: an inducible enzyme (heme oxygenase-1 [HO-1, Hmox1]) and a constitutive isoform (HO-2, Hmox2) (1). Recently, a third isoform (HO-3) was identified that shares approximately 90% amino acid homology with HO-2 (33). Table 1 summarizes some of the salient features of the different isoforms of heme oxygenase. These isozymes are products of different genes, with HO-1 and HO-2 sharing only roughly 40% amino acid homology (1,34). In this review, the term heme oxygenase will refer to HO-1 unless otherwise specified. HO-1 and HO-2 differ primarily in regulation and tissue distribution. HO-1 is ubiquitously distributed in mammalian tissues, and HO-2 is constitutively expressed in the brain, testes, endothelium, medullary thick ascending limb segment of the rat kidney, liver (hepatocytes and sinusoidal endothelial cells), and myenteric plexus of the gastrointestinal tract (1,35,36,37,38). It has been suggested that HO-2 may function as a physiologic regulator of cellular function, whereas HO-1 plays a role in modulating tissue responses to injury in pathophysiologic states (39).

View this table:
Table 1.

Characteristics of the different heme oxygenase isoformsa

The beneficial effects of HO-1 induction occur via several postulated mechanisms (6). Increased HO-1 activity results in degradation of the heme moiety, which is pro-oxidant and potentially toxic (40,41,42). Several cellular targets including lipid bilayers, mitochondria, cytoskeleton, and components of the nucleus are prone to damage by heme (42). In addition to detoxifying heme, elevated HO-1 activity results in the generation of bilirubin, an antioxidant capable of scavenging peroxy radicals and inhibiting lipid peroxidation (43,44). Ferritin, an intracellular repository for iron, is coinduced with HO-1 allowing safe sequestering of the unbound iron liberated during the degradation of heme (45). More recently, modulation of intracellular iron stores and increased iron efflux has been suggested as a mechanism for the cytoprotective effects of HO-1 expression (46). Finally, CO has received considerable attention as a signaling molecule similar to NO (1,47,48,49). CO has vasodilatory effects mediated via cGMP (50), and also possesses antiapoptotic as well as cytoprotective functions (14,49). The biologic effects of CO are summarized in Table 2.

View this table:
Table 2.

Effects of carbon monoxide

Diseases Associated with HO-1

HO-1 has also been implicated in several clinically relevant disease states, including atherosclerosis (51,52,53), hypertension (54), acute renal injury (55), toxic nephropathy (56), transplant rejection (10,11,57), endotoxic shock (17), chronic obstructive lung disease (58), and Alzheimer's disease (59), as well as others (60,61,62,63,64,65,66,67). An abundance of HO-1 mRNA and protein has been identified in human atherosclerotic plaques, providing in vivo relevance to this enzyme in atherosclerosis (51). The major stimulus for the induction of HO-1 in atherosclerotic plaques is oxidized LDL (21,22,23,24) and, more specifically, its fatty acid component linoleyl hydroperoxide (25). The observation that the induction of HO-1 inhibits monocyte chemotaxis demonstrates the functional significance of HO-1 expression in atherosclerosis (52). Furthermore, the beneficial attributes of HO-1 may counteract the potential toxic effects of oxidized LDL. Microsatellite polymorphisms in the human HO-1 gene promoter, specifically the length of a dinucleotide (GT) repeat in the 5′ flanking region, is reported to be associated with susceptibility to emphysema in smokers (58). No similar polymorphisms have as yet been identified in any renal disorder. A list of renal and extrarenal diseases associated with HO-1 is shown in Table 3.

View this table:
Table 3.

Pathologic conditions associated with HO-1a

Expression of HO-1 in the Kidney

HO-1 is induced in the kidney in certain models of acute renal injury: glycerol-induced acute renal failure (55), nephrotoxic serum nephritis (68), and cisplatin nephrotoxicity (56). Induction of HO-1 has been demonstrated in renal tubules in a rat model of rhabdomyolysis and nephrotoxic serum nephritis (55,68). We have observed induction of HO-1 in both proximal and distal tubules in a rat model of cisplatin nephrotoxicity (Figure 2A). Glomerular expression of HO-1 mRNA (69) and protein (Figure 2B) (A. Agarwal and K. A. Nath, unpublished observations) has been reported in animal models of diabetes. In acute renal transplant rejection, HO-1 is dramatically elevated in infiltrating cells (Figure 2C), which have been identified as macrophages (10). The exact subcellular localization of HO-1 along the nephron has not been reported. The reasons for the differences in regional induction of HO-1 in renal injury are not entirely clear. It is interesting to speculate that the site-specific expression along the nephron or in the interstitium occurs due to proximity of the stimulus. Perhaps delivery of heme proteins to the proximal tubule results in proximal tubular induction. Inflammatory cytokines that mediate transplant rejection may induce HO-1 in infiltrating interstitial cells, and increased oxidant stress in diabetic glomeruli results in glomerular expression of HO-1. Recent studies have reported low levels of constitutive expression of HO-1 in the renal inner medulla, where it may contribute to the maintenance of renal medullary circulation (70).

Figure 2.
Figure 2.

Heterogeneity of heme oxygenase-1 (HO-1) expression in renal injury. Frozen renal tissue sections were stained with a polyclonal anti-rat HO-1 antibody as the primary antibody and goat anti-rabbit IgG conjugated with FITC as the secondary antibody. (A) Immunofluorescence studies performed in saline (control) and cisplatin-treated (6 mg/kg body wt, intravenously) rat kidneys at day 5 demonstrate positive staining in renal tubules in the cisplatin-treated animals. (B) In a rat model of streptozotocin-induced diabetes mellitus, HO-1 is induced in glomeruli within 1 wk of onset of diabetes, whereas no induction is seen in saline-treated (control) glomeruli. (C) Positive staining for HO-1 (green, arrow) is observed in infiltrating macrophages but not in renal tubules in a rat model of renal allograft rejection. Nuclei were counterstained with ethidium bromide (orange, arrowhead).

In acute renal injury, previous studies using chemical inducers and inhibitors of HO-1 have demonstrated that expression of HO-1 in renal tubules is cytoprotective in both heme (55) and non-heme-mediated models of renal failure (56). For example, in heme-mediated renal injury in a rat model of acute renal failure associated with rhabdomyolysis, administration of a specific inhibitor of HO-1, tin protoporphyrin, worsened renal damage while prior induction with hemoglobin led to a considerable decrease in mortality (55). In cisplatin-induced toxic nephropathy, a model of acute renal injury not directly dependent on the delivery of heme proteins to the kidney, inhibition of HO-1 by tin protoporphyrin significantly worsened both structural and functional parameters of renal injury, providing indirect evidence for a role of HO-1 in this model (56). Induction of HO-1 mRNA and protein also occurs in gentamicin nephrotoxicity. In contrast to the cisplatin model, HO-1 inhibition does not influence the course of renal functional impairment in gentamicin nephrotoxicity, thus suggesting heterogeneity in the functional significance of HO-1 induction in the kidney (56).

The initial observations in the above studies of acute renal injury have been further corroborated by studies in HO-1 knockout mice in both the glycerol model of rhabdomyolysis (71) and cisplatin-induced acute renal failure (72). Studies using HO-1 knockout mice help to define a precise role for HO-1 in acute renal injury because the potential pitfalls of pharmacologic maneuvers (chemical inducers and inhibitors), which have effects beyond altering HO-1 activity per se, are eliminated. Specifically, the metalloporphyrin inhibitors of HO-1 affect other enzyme systems such as NO synthase and guanylate cyclase, in addition to other nonspecific effects (73,74,75). Moreover, although selective overexpression of HO-1 is cytoprotective against heme protein and cisplatin-mediated toxicity, studies using heme proteins or metalloporphyrins as modulators of HO-1 activity have yielded contrasting results (76,77).

HO-1 Knockout Mouse

Poss and Tonegawa (78) generated mice deficient in HO-1 by targeted deletion of a 3.7-kb region including exons 3 and 4 and a portion of exon 5 of the mouse HO-1 gene. Using standard procedures for generating knockout mice, they developed heterozygote mice in the 129/Sv x C57BL/6 hybrid strain background. A partial prenatal loss of HO-1-deficient mice resulted in a less than expected number of homozygote (-/-) mice with heterozygote (+/-) mating pairs. No viable litters were obtained with (-/-) matings. Using in vitro fertilization with gametes from (-/-) and (+/-) animals, additional (-/-) mice were generated. The adult (-/-) mice were smaller than the wild-type (+/+) mice and exhibited a normochromic, microcytic anemia. Kidneys of (-/-) mice over 20 wk of age showed evidence of iron deposition in renal cortical tubules. Similar iron deposition was also observed in the liver. A progressive chronic inflammation characterized by hepatosplenomegaly, lymphadenopathy, leukocytosis, hepatic periportal inflammation, and occasionally glomerulonephritis was reported in addition to the iron deposition (78). On the basis of these observations, the authors indicated that the HO-1 knockout mouse would be a useful model for studying iron metabolism.

These authors also reported that embryonic fibroblasts from the HO-1-deficient animals were more sensitive to oxidant stimuli such as heme, hydrogen peroxide, paraquat, and cadmium (12). In vivo administration of endotoxin to (-/-) mice (6 to 9 wk of age) resulted in significantly more liver injury and mortality (12), suggesting that expression of HO-1 is an important defense against oxidant stress. More recently, the first known case of human HO-1 deficiency was reported in a 6-yr-old boy (79). Several phenotypical similarities were observed between this patient and the HO-1 knockout mouse, including growth failure, anemia, increased iron binding capacity and ferritin, tissue iron deposition, lymphadenopathy, leukocytosis, and increased sensitivity to oxidant injury (78,79). The patient underwent a renal biopsy for evaluation of hematuria and proteinuria. Mild mesangial proliferation and thickening of the capillary loops were observed in the glomeruli. In addition, endothelial swelling and detachment with subendothelial deposits were also evident in the glomeruli (79). Similar to the HO-1 knockout mouse, iron deposition was present in the liver parenchymal cells, Kupffer cells, and in proximal tubule cells of the kidney (79).

Using the glycerol model of heme protein toxicity in the HO-1 knockout mice, Nath et al. (71) observed significantly worse renal function and tubular injury accompanied by 100% mortality in the (-/-) mice compared with (+/+) mice (71). In addition, both younger (7 to 10 wk) and older (20 to 30 wk) HO-1 knockout mice were more sensitive to the administration of the heme protein (hemoglobin), resulting again in severe renal failure and increased mortality (71). We have also demonstrated that HO-1 gene expression modulates cisplatin-mediated renal tubular injury both in vivo and in vitro (72). Transgenic mice deficient in HO-1 (-/-) develop more severe renal failure and have significantly greater renal injury (apoptosis and necrosis) compared with (+/+) mice treated with cisplatin (Figure 3, A through D). Renal tissue sections of HO-1 (-/-) mice examined at day 3 after cisplatin administration demonstrated increased evidence of acute renal injury characterized by tubular necrosis, degeneration, casts, loss of brush border, and red blood cell extravasation compared with HO-1 (+/+) mice, which showed only mild changes (Figure 3, A and B). In our model of cisplatin nephrotoxicity, a higher degree of apoptosis (confirmed by the terminal deoxynucleotidyl transferase-mediated nick end labeling assay and electron microscopy) was seen in both proximal and distal tubules of HO-1 (-/-) mice kidneys (Figure 3, C and D) (72). In vitro studies in human renal epithelial cells demonstrated that overexpression of HO-1 resulted in a significant reduction in cisplatin-induced cytotoxicity (72).

Figure 3.
Figure 3.

Cisplatin-induced renal injury in the HO-1 knockout mouse. Light microscopy of kidneys from HO-1 (+/+) and HO-1 (-/-) mice stained with hematoxylin and eosin at day 3 after cisplatin administration. (A) Cisplatin-treated HO-1 (+/+) mice kidneys showing mild changes of acute renal injury. (B) Cisplatin-treated HO-1 (-/-) mice kidneys have more severe changes of renal injury with tubular necrosis and loss of brush border, red cell extravasation (arrowhead), and tubular casts. (C and D) Apoptotic nuclei in kidneys of mice treated with cisplatin (20 mg/kg, intraperitoneal injection) at day 3. A threefold increase in the degree of apoptosis as identified by positive terminal deoxynucleotidyl transferase-mediated nick end labeling staining in kidney nuclei (arrowheads) was present in the HO-1 (-/-) mice compared with the HO-1 (+/+) mice. Magnification, ×100. (Inset) Higher magnification (×400) showing an apoptotic nucleus in the renal tubule of an HO-1 (-/-) mouse kidney. Reprinted with permission from Am J Physiol (72).

Expression of HO-1 has been linked to prolonged xenograft survival; hearts transplanted from HO-1 knockout mice showed shortened survival (3 d versus >60 d) compared with hearts obtained from (+/+) or (+/-) mice in the presence of complement inhibitors, cyclosporine, and cobra venom factor (11). Amersi et al. (80) have also demonstrated that overexpression of HO-1, using either cobalt protoporphyrin or gene transfer using an adenoviral vector containing HO-1, attenuated ischemia-reperfusion injury and prolonged survival after cold ischemia/isotransplantation of fatty livers in the obese Zucker rat. These studies will aid in strategies to increase the availability of donor organs in transplantation by salvaging cadaveric organs from older individuals or those with suboptimal function (81).

There are two potential problems for investigators who anticipate performing studies using the HO-1 knockout mice. First, the partial prenatal lethality limits the number of (-/-) mice that can be obtained in a short period of time, necessitating the maintenance of large breeding colonies resulting in high animal care costs. Second, the phenotype of the knockout which is characterized by tissue iron deposition that is observed beyond 20 wk of age is important to note, because such inherent changes could affect the results of experiments. The use of young mice (<8 to 10 wk) would potentially obviate this problem.

HO-1 in Inflammation

In addition to the pathogenesis of acute renal injury, HO-1 plays an important role in the inflammatory response (9). Willis et al. (9) reported the beneficial effects of heme oxygenase upregulation in a model of pleural inflammation. Inhibition of HO-1 using tin protoporphyrin significantly worsened inflammatory exudate and cell number, while prior induction with iron protoporphyrin showed a significant reduction in inflammatory cell infiltration and exudate, suggesting that HO-1 activity modulates the inflammatory response. Similar findings have been reported in other models of inflammation as well (53,68). Vogt et al. (68) demonstrated a novel phenomenon of acquired resistance to renal tubular injury in acute glomerular inflammation that was dependent on the induction of HO-1 in renal tubules. Expression of HO-1 is also protective in hyperoxia-induced lung injury (63). The generation of carbon monoxide appears to be the mechanism involved in this model since exogenous administration of carbon monoxide protects against hyperoxia-induced lung injury (49), results that are similar to gene delivery studies with HO-1 (63).

HO-1 in Transplant Rejection

Induction of HO-1 occurs in immune-mediated renal injury, as demonstrated by the expression of this protein in infiltrating macrophages in acute renal transplant rejection (Figure 2C) (10). The novel observation of Soares et al. (11) that the expression of HO-1 was clearly associated with xenograft survival has provided functional significance of HO-1 induction in transplant rejection. Studies by Hancock et al. (57) have provided convincing data that induction of protective genes such as HO-1 also protects allografts from chronic rejection. In addition to transplant rejection, HO-1 induction also attenuates ischemia/reperfusion injury that affects donor organ quality and subsequent transplantation (80,81). Recently, RDP1258, a novel peptide derived from the HLA class I heavy chain, has been shown to possess immunoregulatory function in vitro and in vivo via modulation of HO-1 enzyme activity (82,83). Administration of RDP1258 was associated with a decrease in graft infiltrating cells and prolongation of cardiac allograft survival (82). Similar results were obtained in a rat renal allograft model (83). These recent developments provide new therapeutic approaches in the quest for prolongation of graft survival and the overall success of organ transplantation.

Molecular Regulation of HO-1

The cellular processes underlying HO-1 induction are complex and tightly regulated; however, one feature common to most of the stimuli that upregulate HO-1 is a significant shift in cellular redox. The induction of HO-1 in response to heme, heavy metals (cobalt chloride, cadmium), NO and NO donors, oxidized LDL (specifically the fatty acid component, linoleyl hydroperoxide), and by cytokines has been demonstrated to be a consequence of de novo transcription (7,15,25,27,28,84,85,86).

Consensus binding sites for NF-κB, AP-1, AP-2, and interleukin-6 responsive elements, as well as other transcription factors, have been reported in the promoter region of the HO-1 gene (7,87), suggesting a potential role for these trans-acting factors in modulating HO-1 gene expression. The regulation of HO-1 may also be species- or cell-specific. For example, the promoter of the rat HO-1 gene has a metal-dependent and heat shock-responsive element, although the heat shock element is not functional in the human HO-1 gene (88,89). In fact, the HO-1 gene has the distinction of being referred to as HSP32, because it is induced by heat shock in rodent cells.

A potential cadmium response element has been identified 5′ to the transcriptional initiation site of the human HO-1 gene, between -4.5 and -4 kb (84). In the mouse HO-1 gene, Alam et al. (86) have described two distal enhancers, one at -4.0 and another at -10 kb, that are required for induction of HO-1 in response to heme, heavy metals, hydrogen peroxide, and sodium arsenite. We have shown that an approximately 4.5-kb human HO-1 gene promoter fragment, which responds to known inducers of the gene such as heme and cadmium, does not completely recapitulate the induction of the gene seen by steady-state Northern analysis, and also lacks the cis-acting elements necessary for linoleyl hydroperoxide-dependent gene induction (25). The absence of a response with the 4.5-kb human HO-1 gene promoter fragment to linoleyl hydroperoxide is further corroborated by the failure of this fragment to respond to other stimuli that directly increase de novo HO-1 gene transcription, i.e., hydrogen peroxide, hyperoxia, and iron/hyperoxia (27). It is possible, therefore, that the human HO-1 gene also requires distal enhancer element(s) similar to the mouse HO-1 gene for induction. Experiments using additional promoter transfections, chromatin structure analysis, and in vivo footprinting are currently under way in our laboratory to delineate the region of the human HO-1 gene that controls induction.

Future Research Opportunities

The availability of the HO-1 knockout mouse will facilitate studies aimed at evaluating a direct role for HO-1 in physiology and pathophysiology. In tandem, studies using either generation of transgenic mice that overexpress HO-1 at specific sites in the kidney or gene transfer of HO-1 to tissue-specific sites will greatly expand this area of investigation. Whole animal experiments, as well as isolated cells grown from different segments of the nephron from these animals, could be used in models of renal injury. Ultrastructural localization of the different isoforms of heme oxygenase along the nephron and functional correlation in the intact kidney and in renal injury will be important. The beneficial effects of products of the HO-1 catalyzed reaction merit further investigation. In this regard, the physiologic role of carbon monoxide, a potentially poisonous gas, needs clear elucidation. Recent studies demonstrate that like NO, low concentrations of CO are protective, whereas higher concentrations are cytotoxic (14). The hemodynamic effects of CO, mediated via cGMP, in the renal microcirulation and other vascular beds are promising (70). Major areas of research in which HO-1 will play a significant role in the near future will be transplantation, inflammation, and the cell biology of acute renal failure (ischemic and nephrotoxic). Other areas related to nephrology include the role of HO-1 in hypertension, diabetic nephropathy, obstructive uropathy, and polycystic kidney disease.

Conclusion

In summary, the induction of HO-1 plays an important role in many clinically relevant disorders, including those that involve the kidney. The availability of the HO-1 knockout mouse has served as a useful tool to further confirm the results in renal injury models that were derived mainly from studies using chemical inducers and inhibitors of HO-1. These observations provide impetus for studies aimed at the development of novel physiologically relevant inducers of the endogenous HO-1 gene or targeted gene overexpression of HO-1 as a therapeutic and preventive modality in pathophysiologic states. Evaluation of the by-products of the HO-1 catalyzed reaction such as iron, biliverdin, bilirubin, and carbon monoxide in mediating the cytoprotective effects will provide further elucidation on the mechanism of cytoprotection. At least one by-product, carbon monoxide, has received considerable attention in recent years. As noted in a research news article from Science, “...this gas is likely to provide fuel to run plenty of labs” (90).

Acknowledgments

This work was supported by grants from the Juvenile Diabetes Foundation International Fellowship Award to Dr. Agarwal in Dr. Nath's laboratory at the University of Minnesota; National Institutes of Health (NIH) Grants K08 DK02446 and R03 DK56279 to Dr. Agarwal; and NIH Grant HL39593 to Dr. Nick. We gratefully acknowledge the contribution of Dr. Karl A. Nath in the studies presented in this review.

Footnotes

  • American Society of Nephrology

References

  1. ↵
    Maines MD: The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol37 : 517-554,1997
    OpenUrlCrossRefPubMed
  2. ↵
    Tenhunen R, Marver HS, Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 61: 748-755,1968
    OpenUrlFREE Full Text
  3. ↵
    Tenhunen R, Marver HS, Schmid R: Microsomal heme oxygenase: Characterization of the enzyme. J Biol Chem244 : 6388-6394,1969
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Stocker R: Induction of haem oxygenase as a defence against oxidative stress. Free Radical Res Commun9 : 101-112,1990
    OpenUrlCrossRefPubMed
  5. ↵
    Keyse SM, Tyrrell RM: Heme oxygenase is the major 32-kDa stress protein induced in skin fibroblasts by UVA radiation, hydrogen peroxide and sodium arsenite. Proc Natl Acad Sci USA86 : 99-103,1989
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Platt JL, Nath KA: Heme oxygenase: Protective gene or Trojan horse. Nat Med 4:1364 -1365, 1998
    OpenUrlCrossRefPubMed
  7. ↵
    Choi AMK, Alam J: Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol15 : 9-19,1996
    OpenUrlCrossRefPubMed
  8. ↵
    Elbirt KK, Bonkovsky HL: Heme oxygenase: Recent advances in understanding its regulation and role. Proc Assoc Am Physicians 111:438 -447, 1999
    OpenUrlPubMed
  9. ↵
    Willis D, Moore AR, Frederick R, Willoughby DA: Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 2: 87-90,1996
    OpenUrlCrossRefPubMed
  10. ↵
    Agarwal A, Kim Y, Matas AJ, Alam J, Nath KA: Gas-generating systems in acute renal allograft rejection in the rat: Co-induction of heme oxygenase and nitric oxide synthase. Transplantation61 : 93-98,1996
    OpenUrlCrossRefPubMed
  11. ↵
    Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, Bach FH: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med4 : 1073-1077,1998
    OpenUrlCrossRefPubMed
  12. ↵
    Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase-1 deficient cells. Proc Natl Acad Sci USA94 : 10925-10930,1997
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Petrache I, Otterbein LE, Alam J, Wiegand GW, Choi AMK: Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts. Am J Physiol Lung Cell Mol Physiol278 : L312-L319,2000
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Thom SR, Fisher D, Xu YA, Notarfrancesco K, Ischiropoulos H: Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci USA97 : 1305-1310,2000
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Rizzardini M, Terao M, Falciani F, Cantoni L: Cytokine induction of haem oxygenase mRNA in mouse liver: Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J290 : 343-347,1993
  16. ↵
    Terry CM, Clikeman JA, Hoidal JR, Callahan KS: Effect of tumor necrosis factor α and interleukin-1 α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol274 : H883-H891,1998
  17. ↵
    Yet SF, Pellacani A, Patterson C, Tan L, Folta SC, Foster L, Lee WS, Hsieh CM, Perrella MA: Induction of heme oxygenase-1 expression in vascular smooth muscle cells: A link to endotoxic shock. J Biol Chem 272:4295 -4301, 1997
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Kutty RK, Nagineni CM, Kutty G, Hooks JJ, Chader GJ, Wiggert B: Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-β. J Cell Physiol 159:371 -378, 1994
    OpenUrlCrossRefPubMed
  19. ↵
    Truong L, Shiraishi F, Visner GA, Nick HS, Agarwal A: Regulation of heme oxygenase-1 by transforming growth factor-β1 (TGF-β) in human renal proximal tubule cells (HPTC) [Abstract]. J Am Soc Nephrol 9: 488,1998
    OpenUrlAbstract
  20. ↵
    Durante W, Peyton KJ, Schafer AI: Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:2666 -2672, 1999
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Siow RC, Ishii T, Sato H, Taketani S, Leake DS, Sweiry JH, Peason JD, Bannai S, Mann GE: Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidized LDL in cultured vascular smooth muscle cells. FEBS Lett368 : 239-242,1995
    OpenUrlCrossRefPubMed
  22. ↵
    Basu-Modak S, Luscher P, Tyrrell RM: Lipid metabolite involvement in the activation of the human heme oxygenase-1 gene. Free Radical Biol Med 20:887 -897, 1996
    OpenUrlCrossRefPubMed
  23. ↵
    Agarwal A, Balla J, Balla G, Croatt AJ, Vercellotti GM, Nath KA: Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 271:F814 -F823, 1996
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ: Induction of heme oxygenase-1 inhibits monocyte transmigration induced by mildly oxidized LDL. J Clin Invest100 : 1209-1216,1997
    OpenUrlCrossRefPubMed
  25. ↵
    Agarwal A, Shiraishi F, Visner GA, Nick HS: Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J Am Soc Nephrol 9:1990 -1997, 1998
    OpenUrlAbstract
  26. ↵
    Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI: Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest100 : 589-596,1997
    OpenUrlCrossRefPubMed
  27. ↵
    Fogg S, Agarwal A, Nick HS, Visner GA: Iron regulates hyperoxia-dependent human human heme oxygenase-1 gene expression in pulmonary endothelial cells. Am J Respir Cell Mol Biol20 : 797-804,1999
    OpenUrlCrossRefPubMed
  28. ↵
    Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI: Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res80 : 557-564,1997
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Datta PK, Lianos EA: Nitric oxide induces heme oxygenase-1 gene expression in mesangial cells. Kidney Int55 : 1734-1739,1999
    OpenUrlCrossRefPubMed
  30. ↵
    Liang M, Croatt AJ, Haggard JJ, Knox FG, Nath KA: Nitric oxide upregulates heme oxygenase-1 in LLC-PK1 cells [Abstract]. J Am Soc Nephrol 10: 635,1999
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Foresti R, Clark JE, Green CJ, Motterlini R: Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: Involvement of superoxide and peroxynitrite anions. J Biol Chem 272:18411 -18417, 1997
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Foresti R, Sarathchandra P, Clark JE, Green CJ, Motterlini R: Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: A link to apoptosis. Biochem J 339:729 -736, 1999
  33. ↵
    McCoubrey WK, Huang TJ, Maines MD: Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247:725 -732, 1997
    OpenUrlPubMed
  34. ↵
    Kutty RK, Kutty G, Rodriguez IR, Chader CJ, Wiggert B: Chromosomal localization of the human heme oxygenase genes: Heme oxygenase-1 (Hmox1) maps to chromosome 22q12 and heme oxygenase-2 (Hmox2) maps to chromosome 16p13.3. Genomics 20:513 -516, 1994
    OpenUrlCrossRefPubMed
  35. ↵
    Suematsu M, Ishimura Y: The heme oxygenase-carbon monoxide system: A regulator of hepatobiliary function. Hepatology31 : 3-6,2000
    OpenUrlCrossRefPubMed
  36. ↵
    Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, Snyder SH: Heme oxygenase 2: Endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA 93: 795-798,1996
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Dore S, Takahashi M, Ferris CD, Hester LD, Guastella D, Snyder SH: Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA96 : 2445-2450,1999
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Liu H, Mount DB, Nasjletti A, Wang W: Carbon monoxide stimulates the apical 70-pS K+ channel of the rat thick ascending limb. J Clin Invest 103:963 -970, 1999
    OpenUrlPubMed
  39. ↵
    Wagener FA, da Silva JL, Farley T, de Witte T, Kappas A, Abraham NG: Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 291:416 -423, 1999
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Balla G, Vercellotti GM, Muller-Eberhard U, Eaton JW, Jacob HS: Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest64 : 648-655,1991
    OpenUrlPubMed
  41. ↵
    Balla, J, Jacob HS, Balla G, Nath KA, Eaton JW, Vercellotti GM: Endothelial cell heme uptake from heme proteins: Sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90:9285 -9289, 1993
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H: Intracellular targets in heme protein-induced renal injury. Kidney Int 53: 100-111,1998
    OpenUrlCrossRefPubMed
  43. ↵
    Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiologic significance. Science 235:1043 -1046, 1987
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Llesuy SF, Tomaro ML: Heme oxygenase and oxidative stress: Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta1223 : 9-14,1994
    OpenUrlPubMed
  45. ↵
    Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM: Ferritin: A cytoprotective antioxidant stratagem of endothelium. J Biol Chem 267:18148 -18153, 1992
    OpenUrlAbstract/FREE Full Text
  46. ↵
    Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, Snyder SH: Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1:152 -157, 1999
    OpenUrlCrossRefPubMed
  47. ↵
    Marks GS, Brien JF, Nakatsu K, McLaughlin BE: Does carbon monoxide have a physiological function? Trends Pharmacol Sci12 : 185-188,1991
    OpenUrlCrossRefPubMed
  48. ↵
    Dawson TM, Snyder SH: Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J Neurosci14 : 5147-5159,1994
    OpenUrlAbstract
  49. ↵
    Otterbein LE, Mantell LL, Choi AMK: Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol276 : L688-L694,1999
  50. ↵
    Morita T, Kourembanas S: Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest96 : 2676-2682,1995
  51. ↵
    Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY: Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol152 : 711-720,1998
    OpenUrlPubMed
  52. ↵
    Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ: Induction of heme oxygenase-1 inhibits monocyte transmigration induced by mildly oxidized LDL. J Clin Invest100 : 1209-1216,1997
  53. ↵
    Siow RCM, Sato H, Mann GE: Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: Anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res41 : 385-394,1999
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Ishizaka N, Leon HD, Laursen JB, Fukui T, Wilcox JN, Keulenaer GD, Griendling KK, Alexander RW: Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation96 : 1923-1929,1997
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg ME: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest90 : 267-270,1992
  56. ↵
    Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298 -1307, 1995
    OpenUrlCrossRefPubMed
  57. ↵
    Hancock WW, Buelow R, Sayegh MH, Turka LA: Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med4 : 1392-1396,1998
    OpenUrlCrossRefPubMed
  58. ↵
    Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H: Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66:187 -195, 2000
    OpenUrlCrossRefPubMed
  59. ↵
    Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Hader GJ, Wiggert B, Petersen RB, Perry G: Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145:42 -47, 1994
    OpenUrlPubMed
  60. ↵
    Levere RD, Staudinger R, Loewy G, Kappas A, Shibahara S, Abraham NG: Elevated levels of heme oxygenase-1 activity and mRNA in peripheral blood adherent cells of acquired immunodeficiency syndrome patients. Am J Hematol 43:19 -23, 1993
    OpenUrlPubMed
  61. ↵
    Sato H, Siow RC, Bartlett S, Taketani S, Ishii T, Bannai S, Mann GE: Expression of stress proteins heme oxygenase-1 and -2 in acute pancreatitis and pancreatic islet betaTC3 and acinar AR42J cells. FEBS Lett 405:219 -223, 1997
    OpenUrlCrossRefPubMed
  62. ↵
    Chen W, Hunt DM, Lu H, Hunt RC: Expression of antioxidant protective proteins in the rat retina during prenatal and postnatal development. Invest Ophthalmol Vis Sci40 : 744-751,1999
    OpenUrlAbstract/FREE Full Text
  63. ↵
    Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM: Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103:1047 -1054, 1999
    OpenUrlCrossRefPubMed
  64. ↵
    Laniado-Schwartzman M, Abraham NG, Conners M, Dunn MW, Levere RD, Kappas A: Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol53 : 1069-1075,1997
    OpenUrlCrossRefPubMed
  65. ↵
    Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ: Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: A new marker of oxidative stress. Thorax 53:668 -672, 1998
    OpenUrlAbstract/FREE Full Text
  66. ↵
    Mautes AE, Kim DH, Sharp FR, Panter S, Sato M, Maida N, Bergeron M, Guenther K, Noble LJ: Induction of heme oxygenase-1 (HO-1) in the contused spinal cord of the rat. Brain Res795 : 17-24,1998
    OpenUrlCrossRefPubMed
  67. ↵
    Matz PG, Weinstein PR, Sharp FR: Heme oxygenase-1 and heat shock protein 70 induction in glia and neurons throughout rat brain after experimental intracerebral hemorrhage. Neurosurgery40 : 152-160,1997
    OpenUrlCrossRefPubMed
  68. ↵
    Vogt BA, Shanley TP, Croatt A, Alam J, Johnson KJ, Nath KA: Glomerular inflammation induces resistance to tubular injury in the rat: A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest 98:2139 -2145, 1996
    OpenUrlCrossRefPubMed
  69. ↵
    Hayashi K, Haneda M, Koya D, Maeda S, Isshiki K, Inoki K, Sugimoto T, Kikkawa R: Preferential enhancement of glomerular heme oxygenase-1 (HO-1) expression in diabetic rats and its reversal by antioxidants [Abstract]. J Am Soc Nephrol 10:682 , 1999
    OpenUrl
  70. ↵
    Zou AP, Billington H, Su N, Cowley AW Jr: Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension 35:342 -347, 2000
    OpenUrlAbstract/FREE Full Text
  71. ↵
    Nath KA, Haggard JJ, Croatt AJ, Grande JP, Poss KD, Alam J: The indispensability of heme oxygenase-1 (HO-1) in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol2000 , in press
  72. ↵
    Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen KM, Nick HS, Agarwal A: Heme oxygenase-1 gene ablation or overexpression modulates cisplatin-induced renal tubular apoptosis and necrosis. Am J Physiol 2000, in press
  73. ↵
    Lutton JD, Abraham NG, Drummond GS, Levere RD, Kappas A: Zinc porphyrins: Potent inhibitors of hematopoiesis in animal and human bone marrow. Proc Natl Acad Sci USA94 : 1432-1436,1997
    OpenUrlAbstract/FREE Full Text
  74. ↵
    Grundemar L, Ny L: Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci18 : 193-195,1997
    OpenUrlCrossRefPubMed
  75. ↵
    Serfass L, Burstyn JN: Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity. Arch Biochem Biophys 359:8 -16, 1998
    OpenUrlCrossRefPubMed
  76. ↵
    Zager RA: Heme protein-induced tubular cytoresistance: Expression at the plasma membrane level. Kidney Int47 : 1336-1345,1995
    OpenUrlPubMed
  77. ↵
    Zager RA, Burkhart KM, Conrad DS, Gmur DJ: Iron, heme oxygenase, and glutathione: Effects on myohemoglobinuric proximal tubular injury. Kidney Int 48:1624 -1634, 1995
    OpenUrlPubMed
  78. ↵
    Poss KD, Tonegawa S: Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA94 : 10919-10924,1997
    OpenUrlAbstract/FREE Full Text
  79. ↵
    Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103:129 -135, 1999
    OpenUrlCrossRefPubMed
  80. ↵
    Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW: Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest104 : 1631-1639,1999
    OpenUrlCrossRefPubMed
  81. ↵
    Nath KA: Heme oxygenase-1: A redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest 104:1485 -1486, 1999
    OpenUrlPubMed
  82. ↵
    Cuturi MC, Christoph F, Woo J, Iyer S, Brouard S, Heslan JM, Pignon P, Soulillou JP, Buelow R: RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: Analysis of its mechanism of action. Mol Med5 : 820-832,1999
    OpenUrlPubMed
  83. ↵
    Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M: In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J Am Soc Nephrol10 : 1997-2005,1999
    OpenUrlAbstract/FREE Full Text
  84. ↵
    Takeda K, Ishizawa S, Sato M, Yoshida T, Shibahara S: Identification of a cis-acting element that is responsible for cadmium-mediated induction of the human heme oxygenase gene. J Biol Chem 269:22858 -22867, 1994
    OpenUrlAbstract/FREE Full Text
  85. ↵
    Alam J, Cai J, Smith A: Isolation and characterization of the mouse heme oxygenase-1 gene: Distal 5′ sequences are required for induction by heme and heavy metals. J Biol Chem269 : 1001-1009,1994
    OpenUrlAbstract/FREE Full Text
  86. ↵
    Alam J, Camhi S, Choi AMK: Identification of a second 5′ distal region that functions as a basal and inducer-dependent transcriptional enhancer of the mouse heme oxygenase-1 gene. J Biol Chem 270:11977 -11984, 1995
    OpenUrlAbstract/FREE Full Text
  87. ↵
    Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG: Identification of binding sites for transcription factors NF-κB and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 91:5987 -5991, 1994
    OpenUrlAbstract/FREE Full Text
  88. ↵
    Okinaga S, Takahashi K, Takeda K, Yoshizawa M, Fujita H, Sasaki H, Shibahara S: Regulation of human heme oxygenase-1 gene expression under thermal stress. Blood 87:5074 -5084, 1996
    OpenUrlAbstract/FREE Full Text
  89. ↵
    Yoshida T, Biro P, Cohen T, Muller RM, Shibahara S: Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem 171:457 -461, 1988
    OpenUrlPubMed
  90. ↵
    Barinaga M: Carbon monoxide: Killer to brain messenger in one step [Abstract]. Science 259:309 , 1993
    OpenUrlFREE Full Text
  91. Maulik N, Sharma HS, Das DK: Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol 28:1261 -1270, 1996
    OpenUrlCrossRefPubMed
View Abstract
Back to top

In this issue

View Selected Citations (0)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Request Permissions
Renal Response to Tissue Injury
ANUPAM AGARWAL, HARRY S. NICK
JASN May 2000, 11 (5) 965-973;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section